 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Kelly James Patrick
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-01-04 Sale | 2016-01-06 7:09 pm | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 9,564 | $8.96 | $85,693 | 60,772 (Direct) | View |
| 2017-01-03 Sale | 2017-01-05 5:01 pm | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 10,895 | $15.51 | $169,013 | 69,721 (Direct) | View |
| 2018-01-02 Sale | 2018-01-04 5:12 pm | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 9,155 | $15.35 | $140,494 | 168,066 (Direct) | View |
| 2018-02-28 Sale | 2018-03-02 5:34 pm | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 8,532 | $18.72 | $159,712 | 199,534 (Direct) | View |
| 2019-01-02 Sale | 2019-01-04 4:33 pm | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 6,061 | $26.37 | $159,811 | 193,473 (Direct) | View |
| 2019-03-01 Sale | 2019-03-04 5:06 pm | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 13,727 | $19.98 | $274,232 | 209,746 (Direct) | View |
| 2020-01-02 Sale | 2020-01-06 5:25 pm | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 4,020 | $15.94 | $64,086 | 205,726 (Direct) | View |
| 2020-03-02 Sale | 2020-03-04 5:01 pm | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 18,857 | $10.36 | $195,446 | 186,869 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-01-04 Exercise | 2016-01-06 7:09 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 4,688 | $0 | 60,772 (Direct) | View |
| 2016-01-04 Exercise | 2016-01-06 7:09 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 2,344 | $0 | 60,772 (Direct) | View |
| 2016-01-04 Exercise | 2016-01-06 7:09 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 60,772 (Direct) | View |
| 2016-01-04 Exercise | 2016-01-06 7:09 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 60,772 (Direct) | View |
| 2016-01-04 Exercise | 2016-01-06 7:09 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 4,688 | $0 | 60,772 (Direct) | View |
| 2016-01-04 Exercise | 2016-01-06 7:09 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 2,344 | $0 | 60,772 (Direct) | View |
| 2016-01-04 Exercise | 2016-01-06 7:09 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 60,772 (Direct) | View |
| 2016-01-04 Exercise | 2016-01-06 7:09 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 60,772 (Direct) | View |
| 2016-02-12 Option Award | 2016-02-17 5:32 pm | N/A 2026-02-11 | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 70,000 | $7.94 | 30,000 (Direct) | View |
| 2016-02-12 Option Award | 2016-02-17 5:32 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 30,000 | $0 | 30,000 (Direct) | View |
| 2017-01-03 Exercise | 2017-01-05 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 2,344 | $0 | 69,721 (Direct) | View |
| 2017-01-03 Exercise | 2017-01-05 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 69,721 (Direct) | View |
| 2017-01-03 Exercise | 2017-01-05 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 69,721 (Direct) | View |
| 2017-01-03 Exercise | 2017-01-05 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 7,500 | $0 | 69,721 (Direct) | View |
| 2017-01-03 Exercise | 2017-01-05 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 2,344 | $0 | 69,721 (Direct) | View |
| 2017-01-03 Exercise | 2017-01-05 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 69,721 (Direct) | View |
| 2017-01-03 Exercise | 2017-01-05 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 69,721 (Direct) | View |
| 2017-01-03 Exercise | 2017-01-05 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 7,500 | $0 | 69,721 (Direct) | View |
| 2017-03-01 Option Award | 2017-03-03 5:31 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 70,000 | $0 | 70,000 (Direct) | View |
| 2017-03-01 Option Award | 2017-03-03 5:31 pm | N/A 2027-02-28 | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 70,000 | $14.5 | 70,000 (Direct) | View |
| 2018-01-02 Exercise | 2018-01-04 5:12 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 168,066 (Direct) | View |
| 2018-01-02 Exercise | 2018-01-04 5:12 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 168,066 (Direct) | View |
| 2018-01-02 Exercise | 2018-01-04 5:12 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 7,500 | $0 | 168,066 (Direct) | View |
| 2018-01-02 Exercise | 2018-01-04 5:12 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 168,066 (Direct) | View |
| 2018-01-02 Exercise | 2018-01-04 5:12 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 5,000 | $0 | 168,066 (Direct) | View |
| 2018-01-02 Exercise | 2018-01-04 5:12 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 7,500 | $0 | 168,066 (Direct) | View |
| 2018-02-28 Option Award | 2018-03-02 5:34 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 40,000 | $0 | 199,534 (Direct) | View |
| 2018-02-28 Option Award | 2018-03-02 5:34 pm | N/A 2028-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 80,000 | $18.85 | 199,534 (Direct) | View |
| 2019-02-27 Option Award | 2019-03-01 4:19 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 30,000 | $0 | 70,000 (Direct) | View |
| 2019-02-27 Option Award | 2019-03-01 4:19 pm | N/A 2029-02-26 | Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO | 70,000 | $20.62 | 70,000 (Direct) | View |